Ascorbic acid Withdrawn Phase 2 Trials for Stage II Multiple Myeloma / Refractory Plasma Cell Neoplasm / Stage III Multiple Myeloma Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00085345Melphalan, Arsenic Trioxide, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma